Skip to main content
Scandinavian Journal of Primary Health Care logoLink to Scandinavian Journal of Primary Health Care
. 2023 Nov 29;41(4):372–376. doi: 10.1080/02813432.2023.2235609

Chronic fatigue syndromes: real illnesses that people can recover from

The Oslo Chronic Fatigue Consortium, Tomas Nordheim Alme a, Anna Andreasson b, Tarjei Tørre Asprusten c, Anne Karen Bakken d,ba, Michael BJ Beadsworth e, Birgitte Boye f,an, Per Alf Brodal g, Elias Myrstad Brodwall h,a, Kjetil Gundro Brurberg i, Ingrid Bugge j, Trudie Chalder k, Reidar Due a, Hege Randi Eriksen m, Per Klausen Fink n, Signe Agnes Flottorp o,bb, Egil Andreas Fors p, Bård Fossli Jensen q, Hans Petter Fundingsrud r, Paul Garner s,#, Lise Beier Havdal a, Helene Helgeland u, Henrik Børsting Jacobsen v,ap, Georg Espolin Johnson w, Martin Jonsjö t,x, Hans Knoop y, Live Landmark z,ap,#, Gunvor Launes aa, Mats Lekander ab, Hannah Linnros ac, Elin Lindsäter ad, Helena Liira ae, Lina Linnestad af, Jon Håvard Loge f, Peter Solvoll Lyby bd, Sadaf Malik a, Ulrik Fredrik Malt aj, Trygve Moe ak, Anna-Karin Norlin ac, Maria Pedersen a,h, Siv Elin Pignatiello an, Charlotte Ulrikka Rask ao, Silje Endresen Reme v,ap,, Gisle Roksund aq, Markku Sainio ar, Michael Sharpe as, Ruth Foseide Thorkildsen at, Betty van Roy a, Per Olav Vandvik av, Henrik Vogt aw, Hedda Bratholm Wyller ax, Vegard Bruun Bratholm Wyller h,a
PMCID: PMC11001335  PMID: 37740918

Abstract

The ‘Oslo Chronic Fatigue Consortium’ consists of researchers and clinicians who question the current narrative that chronic fatigue syndromes, including post-covid conditions, are incurable diseases. Instead, we propose an alternative view, based on research, which offers more hope to patients. Whilst we regard the symptoms of these conditions as real, we propose that they are more likely to reflect the brain's response to a range of biological, psychological, and social factors, rather than a specific disease process. Possible causes include persistent activation of the neurobiological stress response, accompanied by associated changes in immunological, hormonal, cognitive and behavioural domains. We further propose that the symptoms are more likely to persist if they are perceived as threatening, and all activities that are perceived to worsen them are avoided. We also question the idea that the best way to cope with the illness is by prolonged rest, social isolation, and sensory deprivation.Instead, we propose that recovery is often possible if patients are helped to adopt a less threatening understanding of their symptoms and are supported in a gradual return to normal activities. Finally, we call for a much more open and constructive dialogue about these conditions. This dialogue should include a wider range of views, including those of patients who have recovered from them.

Keywords: Chronic fatigue syndrome, Myalgic encephalomyelitis, Long Covid, Chronic illness narrative, Multidimensional explanations, Rehabilitation strategies, Patient-centered care

The current public narrative

Severe, persistent fatigue conditions are a pressing public health issue commonly encountered in primary care settings. There is an increasingly dominant public narrative that these fatigue conditions are best understood as chronic and incurable multisystem diseases, often coupled with the prediction that patients cannot recover and that activity is harmful [1–3]. This narrative is most commonly expressed by campaigners concerned with chronic fatigue syndrome (CFS)/myalgic encephalomyelitis (ME) [4], but more recently by those writing about post-covid-19 condition [5], often referred to as Long Covid. As a Consortium of researchers, academics, and clinicians interested in the causes and treatments of fatigue and fatigue related conditions, as well as representatives of patients who have suffered from these illnesses themselves, we propose that a different narrative also needs to be heard. This alternative narrative is based on scientific evidence and offers patients a realistic hope of improvement and recovery.

Current diagnostic labels are of limited value

Diagnoses guide treatment. However, although many of the diagnoses given to patients with these fatigue related conditions, such as CFS/ME, post-covid-19 conditions and burnout, have questionable validity and reliability [1,6–8], and indeed overlap [9], they imply quite different treatments. Persistent fatigue also occurs in many other illnesses [7,10–12] and is therefore unlikely to indicate a distinct illness with specific pathology [13]. Furthermore, post-exertional malaise (PEM), thought by some to be specific to CFS/ME, also occurs in patients with other diagnoses [1]. Given this lack of evidence for the specificity of the diagnosis of CFS/ME [14], it is surprising that it has often been portrayed as a distinct disease requiring treatment different to that from other similar conditions (for example [1,2]).

It is time for another perspective

After 40 years of research into CFS/ME [15] neither a specific biological defect or pathology, nor a specific biomarker, has been identified. Whilst many pathophysiological abnormalities have been reported, these remain as non-specific associations. Similar abnormalities have also been found in patients with other illnesses including chronic pain and fibromyalgia [16,17], as well as in illnesses conventionally referred to as ‘psychological’ [18–20]. We therefore think it is time to explore alternative perspectives that include psychological, social as well as biological factors [21].

Symptoms are both real and generated by the brain

This new perspective views the symptoms of these fatigue related conditions as real. These symptoms, like all perceptions, arise from synchronized activity of complex neural networks in the brain. Whilst such activity may be driven by signals arising in the tissues of the body, it may occur without such signals [22]. The experience of pain, for example, can arise from expectations based on prior experience, without any neuronal input from peripheral sense organs and influenced by the interplay of biological, psychological, and social factors [23–26].

These conditions can be explained

Research from several fields including neuroscience, evolutionary biology, and physiology provides promising explanations for understanding symptom onset, development, and persistence. Faced by perceived threats to our wellbeing, our brain networks generate alarms in the form of symptoms, such as fatigue and pain, to warn us and shut us down. These alarms may be seen as crucial processes selected through evolution to keep us safe. More specifically, pain signals tissue damage, and fatigue signals a disbalance between effort needed, expected reward and available resources [27], but they are also regulated and influenced by context. These perceived threats to our safety can evoke a stress response of automated bodily defense mechanisms consisting of interlinked immunological, hormonal, cognitive, and behavioral adjustments. This response is initially temporary and adaptive, but may become persistent and maladaptive chronically affecting sleep and cognitive functioning [28,29]. A high level of neuroplasticity in this alarm system risks associative learning, whereby the alarms are reactivated by innocent cues (by classical conditioning). The way we experience a situation is strongly influenced by our previous experience and expectations [22,30,31]. Other processes that contribute to symptom persistence include unconscious bias in attention and interpretation, sensitization to stimuli and changes in perception effort [32].

Activity as well as rest is needed for rehabilitation

Building on this understanding, the presence of fatigue and other symptoms after activity does not necessarily mean that such activity is dangerous or that there is ‘lack of energy in the body’. Rest is beneficial after acute stressors, such as an infection, but a gradual and controlled approach to increasing activity is crucial for rehabilitation. Patients should feel secure and in control throughout the process. Such rehabilitation can reduce symptoms by allowing the systems described above to readapt to activity [33], and can be readily delivered in primary care. By contrast, the approach often recommended by the public narrative of inactivity, isolation, and sensory deprivation, risks worsening symptoms and associated disability [34–36].

Patients do recover and get back to work [37,38], and patients can get help that improves their chances of recovery [39]. Giving them credible and positive explanations of their symptoms gives them hope that they will be able to return to valued activities [40,41]. Individualized rehabilitative treatments such as cognitive behavioral therapy (CBT) and graded exercise therapy (GET), based on this understanding and given within a supportive therapeutic relationship, help patients to gain control of their illness [42]. When given correctly by appropriately trained therapists these treatments can offer useful improvement for many and recovery for some [43].

We need to explore all avenues that may lead to effective treatments

We are well aware that some patients have met mistrust and even dismissal of their suffering and may also feel that their illness is stigmatized. These experiences are regrettable, should not have happened and can result in patients feeling scared and angry. We are also aware that some feel that this dismissal justifies a defensive narrative that decries the involvement of psychological and social factors and promotes the idea of an ‘incurable physical disease’. In order to maintain the dominance of this narrative any patients, clinicians, and researchers who question it may be attacked, harassed and unfairly charged with conspiring against vulnerable patients [44]. We believe such actions to be unethical and incompatible with good science and properly informed patient care.

The patient voice is important and must include the recovered

We do believe that the patients´ voice is important and that this voice must include those who improved or recovered from the illness, and not just those who remain ill [45,46]. Those who have improved or recovered through cognitive, behavioural, and stress-reducing strategies can offer special insight into both the experience of illness and the ways out of it. Unfortunately, their personal stories are rarely promoted or represented by advocacy groups as they do not match the ‘incurable physical disease’ narrative.

The unproven narrative of a disease with no cure can be harmful

The narrative of CFS/ME as an incomprehensible and incurable disease without any available treatment is likely to increase fear, helplessness, and loss of hope. The associated advice to rest whilst awaiting a medical cure both discourages patients from gaining control of their symptoms and creates a barrier to seeking potentially effective treatments, as well as risking worsening of symptoms and reduced quality of life. Unfortunately, this narrative is now being promoted for post-covid-19 conditions, risking a further major negative impact on public health.

What is needed now?

We call for change. Specifically, we propose that doctors and health professionals should feel free to discuss and express different understandings of these illnesses. They should also be free to recommend any evidence-based treatments that offer a realistic hope of improvement and even recovery. In summary, we need a broader more constructive and better-informed public narrative about these disabling illnesses, if we are to make real progress in helping those who are suffering from them.

Disclosure statement

Trudie Chalder has received royalties for self-help books on chronic fatigue and ad hoc payments for workshops on long-term conditions and travel expenses and accommodation costs of attending conferences. She is on the Expert Advisory Panel for Covid-19 Rapid Guidelines and is in receipt of research grants from Guy’s and St Thomas’ Charity, NIHR and UKRI. Hege Eriksen is cofounder and part owner of Stressprofessorene, giving paid lectures on stress and coping. Henrik B Jacobsen receives honorariums for lectures and workshops about stress and health. Hans Knoop receives royalties for a published manual of cognitive behavior therapy for ME/CFS. Live Landmark receives honorarium for lectures about stress and coping and payment as an instructor in the Lightning Process. Helena Liira is the former Editor in Chief of the Scandinavian Journal of Primary Health Care. Silje E Reme receives honorariums for lectures and workshops about stress and health. Michael Sharpe is President of the European Association of Psychosomatic medicine and receives royalties for academic publications. Henrik Vogt initiated and was the former leader of Recovery Norway which is an organization consisting of people who have experienced recovery from conditions such as post-viral illness like PACS and CFS/ME from 2017 until March 2022 and is still a member of this organization. He discloses this as an intellectual and personal COI but declares no financial or economic conflicts of interest. The remaining authors declare no conflicts of interest relating to this manuscript.

References

  • 1.Institute of Medicine . Beyond myalgic encephalomyelitis/chronic fatigue syndrome: redefining an illness. Washington, D.C: National Academies Press; 2015. [PubMed] [Google Scholar]
  • 2.National Institute for Health and Care Excellence . Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management. 2021. [Google Scholar]
  • 3.The ME association . 2023. General information. https://meassociation.org.uk/me-cfs-general-information/.
  • 4.Johnson C. An Open Letter to the COVID-19 Long Hauler Community From a Person with ME/CFS. 2020. https://www.healthrising.org/blog/2020/07/24/open-letter-covid-19-long-hauler-me-cfs/.
  • 5.Yong E. Long-Haulers are fighting for their future. The Atlantic. 2021. https://www.theatlantic.com/science/archive/2021/09/covid-19-long-haulers-pandemic-future/619941/.
  • 6.Asprusten TT. Diagnosis of chronic fatigue syndrome in adolescents. University og Oslo. 2022. https://www.med.uio.no/klinmed/english/research/news-and-events/events/disputations/2022/asprusten-tarjei-torre.html.
  • 7.Lindsäter E, Svärdman F, Wallert J, et al. Exhaustion disorder: a scoping review of research on a recently introduced stress-related diagnosis. BJ Psych Open. 2022;8(5):e159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.WHO, W. H. O . A clinical case definition of post COVID-19 condition by a Delphi consensus. 2021; [cited 2021 Oct 6]. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1. [DOI] [PMC free article] [PubMed]
  • 9.Hamilton WT, Gallagher AM, Thomas JM, et al. The prognosis of different fatigue diagnostic labels: a longitudinal survey. Fam Pract. 2005;22(4):383–388. doi: 10.1093/fampra/cmi021. [DOI] [PubMed] [Google Scholar]
  • 10.Arnold LM. Understanding fatigue in major depressive disorder and other medical disorders. Psychosomatics. 2008;49(3):185–190. doi: 10.1176/appi.psy.49.3.185. [DOI] [PubMed] [Google Scholar]
  • 11.Galvez-Sánchez CM, Reyes del Paso GA.. Diagnostic criteria for fibromyalgia: critical review and future perspectives. J Clin Med. 2020;9(4):1219. doi: 10.3390/jcm9041219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Goërtz YM, Braamse AM, Spruit MA, et al. Fatigue in patients with chronic disease: results from the population-based lifelines cohort study. Sci Rep. 2021;11(1):1–12. doi: 10.1038/s41598-021-00337-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Petersen MW, Schröder A, Jørgensen T, et al. Irritable bowel, chronic widespread pain, chronic fatigue and related syndromes are prevalent and highly overlapping in the general population: danFunD. Sci Rep. 2020;10(1):1–10. doi: 10.1038/s41598-020-60318-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.WHO . Chronic fatigue syndrome. 2022. https://www.who.int/standards/classifications/frequently-asked-questions/chronic-fatigue-syndrome.
  • 15.Muller AE, Tveito K, Bakken IJ, et al. Potential causal factors of CFS/ME: a concise and systematic scoping review of factors researched. J Transl Med. 2020;18(1):1–7. doi: 10.1186/s12967-020-02665-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Jones AK, McBeth J, Power A.. The biological response to stress and chronic pain. Chronic Pain Epidemiology: from Aetiology to Public Health. 2010:101–118. [Google Scholar]
  • 17.Siracusa R, Paola RD, Cuzzocrea S, et al. Fibromyalgia: pathogenesis, mechanisms, diagnosis and treatment options update. Int J Mol Sci. 2021;22(8):3891. doi: 10.3390/ijms22083891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Blume J, Douglas SD, Evans DL.. Immune suppression and immune activation in depression. Brain Behav Immun. 2011;25(2):221–229. doi: 10.1016/j.bbi.2010.10.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Łoś K, Waszkiewicz N.. Biological markers in anxiety disorders. J Clin Med. 2021;10(8):1744. doi: 10.3390/jcm10081744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.McEwen BS, Bowles NP, Gray JD, et al. Mechanisms of stress in the brain. Nat Neurosci. 2015;18(10):1353–1363. doi: 10.1038/nn.4086. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Saunders C, Sperling S, Bendstrup E.. A new paradigm is needed to explain long COVID. The Lancet Respir Med. 2023;11(2):e12–e13. doi: 10.1016/S2213-2600(22)00501-X. [DOI] [PubMed] [Google Scholar]
  • 22.Van Den Bergh O, Witthöft M, Petersen S, et al. Symptoms and the body: taking the inferential leap. Neurosci Biobehav Rev. 2017;74(Pt A):185–203. doi: 10.1016/j.neubiorev.2017.01.015. [DOI] [PubMed] [Google Scholar]
  • 23.Apkarian AV, Baliki MN, Farmer MA.. Predicting transition to chronic pain. Curr Opin Neurol. 2013;26(4):360–367. doi: 10.1097/WCO.0b013e32836336ad. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Barrett LF, Simmons WK.. Interoceptive predictions in the brain. Nat Rev Neurosci. 2015;16(7):419–429. doi: 10.1038/nrn3950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Brodal P. A neurobiologist’s attempt to understand persistent pain. Scand J Pain. 2017;15(1):140–147. doi: 10.1016/j.sjpain.2017.03.001. [DOI] [PubMed] [Google Scholar]
  • 26.Price DD, Finniss DG, Benedetti F.. A comprehensive review of the placebo effect: recent advances and current thought. Annu Rev Psychol. 2008;59:565–590. doi: 10.1146/annurev.psych.59.113006.095941. [DOI] [PubMed] [Google Scholar]
  • 27.Boksem MA, Tops M.. Mental fatigue: costs and benefits. Brain Res Rev. 2008;59(1):125–139. doi: 10.1016/j.brainresrev.2008.07.001. [DOI] [PubMed] [Google Scholar]
  • 28.McEwen BS, Akil H.. Revisiting the stress concept: implications for affective disorders. J Neurosci. 2020;40(1):12–21. doi: 10.1523/JNEUROSCI.0733-19.2019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Ursin H, Eriksen HR.. The cognitive activation theory of stress. Psychoneuroendocrinology. 2004;29(5):567–592. doi: 10.1016/s0306-4530(03)00091-x. [DOI] [PubMed] [Google Scholar]
  • 30.Kube T, Rozenkrantz L, Rief W, et al. Understanding persistent physical symptoms: conceptual integration of psychological expectation models and predictive processing accounts. Clin Psychol Rev. 2020;76:101829. doi: 10.1016/j.cpr.2020.101829. [DOI] [PubMed] [Google Scholar]
  • 31.Lenaert B, Boddez Y, Vlaeyen JWS, et al. Learning to feel tired: a learning trajectory towards chronic fatigue. Behav Res Ther. 2018;100:54–66. doi: 10.1016/j.brat.2017.11.004. [DOI] [PubMed] [Google Scholar]
  • 32.van der Schaaf ME, Roelofs K, de Lange FP, et al. Fatigue is associated with altered monitoring and preparation of physical effort in patients with chronic fatigue syndrome. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018;3(4):392–404. doi: 10.1016/j.bpsc.2018.01.015. [DOI] [PubMed] [Google Scholar]
  • 33.Hansen AL, Kvale G, Stubhaug B, et al. Heart rate variability and fatigue in patients with chronic fatigue syndrome after a comprehensive cognitive behavior group therapy program. J Psychophysiol. 2013;27(2):67–75. doi: 10.1027/0269-8803/a000088. [DOI] [Google Scholar]
  • 34.Allen C, Glasziou P, Del Mar C.. Bed rest: a potentially harmful treatment needing more careful evaluation. Lancet. 1999;354(9186):1229–1233. doi: 10.1016/s0140-6736(98)10063-6. [DOI] [PubMed] [Google Scholar]
  • 35.Arias D, Otto C.. 2011). Scope of sensory deprivation for long duration space missions. http://www.medirelax.com/v2/wp-content/uploads/2013/11/F.-Scope-of-Sensory-Deprivation-for-Long-Duration-Space-Missions.pdf.
  • 36.Ried-Larsen M, Aarts HM, Joyner MJ.. Effects of strict prolonged bed rest on cardiorespiratory fitness: systematic review and meta-analysis. J Appl Physiol. 2017;123(4):790–799. doi: 10.1152/japplphysiol.00415.2017. [DOI] [PubMed] [Google Scholar]
  • 37.Nyland H, Næss H, Nyland M.. Kartlegging av funksjon ved kronisk utmattelsessyndrom. Tidsskr Nor Laegeforen. 2015;135(17):1540–1541. doi: 10.4045/tidsskr.15.0530. [DOI] [PubMed] [Google Scholar]
  • 38.Rowe KS. Long term follow up of young people with chronic fatigue syndrome attending a pediatric outpatient service. Front Pediatr. 2019;7:e00021. doi: 10.3389/fped.2019.00021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Knoop H, Bleijenberg G, Gielissen MF, et al. Is a full recovery possible after cognitive behavioural therapy for chronic fatigue syndrome? Psychother Psychosom. 2007;76(3):171–176. doi: 10.1159/000099844. [DOI] [PubMed] [Google Scholar]
  • 40.McNarry MA, Berg RM, Shelley J, et al. Inspiratory muscle training enhances recovery post COVID-19: a randomised controlled trial. Eur Respir J. 2022;60(4):2103101. doi: 10.1183/13993003.03101-2021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Philip KE, Owles H, McVey S, et al. An online breathing and wellbeing programme (ENO breathe) for people with persistent symptoms following COVID-19: a parallel-group, single-blind, randomised controlled trial. Lancet Respir Med. 2022;10(9):851–862. doi: 10.1016/S2213-2600(22)00125-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Ingman T, Smakowski A, Goldsmith K, et al. A systematic literature review of randomized controlled trials evaluating prognosis following treatment for adults with chronic fatigue syndrome. Psychol Med. 2022;52(14):2917–2929. doi: 10.1017/S0033291722002471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Sharpe M, Chalder T, White PD.. Evidence-based care for people with chronic fatigue syndrome and myalgic encephalomyelitis. J Gen Intern Med. 2022;37(2):449–452. doi: 10.1007/s11606-021-07188-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Nogrady B. Online harassment: a toolkit for protecting yourself from abuse. Nature. 2022;609(7925):205–207. doi: 10.1038/d41586-022-02766-w. [DOI] [PubMed] [Google Scholar]
  • 45.Living Proof . New insights into chronic pain and illness. 2022. https://www.livingproof.org.uk/mecfs.
  • 46.Recovery Norway . 2022. https://www.recoverynorway.org.

Articles from Scandinavian Journal of Primary Health Care are provided here courtesy of Taylor & Francis

RESOURCES